Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004732 · ClinicalTrials.gov registry record · NA

Carotid Revascularization Endarterectomy Versus Stenting Trial

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
2,502
Enrollment target

NCT00004732 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 2,502 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004732, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
2,502 participants
Enrollment target

Study Summary

The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of stent-assisted carotid angioplasty (CAS) to the traditional and accepted surgical approach of carotid endarterectomy (CEA) for the treatment of carotid artery stenosis to prevent recurrent strokes in those patients who have had a TIA (transient ischemic attack) or a mild stroke within the past 6 months (symptomatic) and in those patients who have not had any symptoms within the past 6 months (asymptomatic).

Interventions

  • PROCEDURE Carotid Endarterectomy (CEA)
  • DEVICE Carotid Artery Stenting (CAS)

Trial Details

FieldValue
Enrollment Target 2,502 participants
Start Date 2000-12
Est. Completion 2016-12
Phase NA

What the Registry Record Tells You About NCT00004732

The ClinicalTrials.gov registry entry for NCT00004732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,502 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Carotid Endarterectomy (CEA) is the first listed.

NCT00004732 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00004732 about?

NCT00004732 is a clinical study titled "Carotid Revascularization Endarterectomy Versus Stenting Trial". The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of stent-assisted carotid angioplasty (CAS) to the traditional and accepted surgical approach of carotid endarterectomy (CEA) for the treatment of carotid artery steno...

What is the current status of trial NCT00004732?

This trial is currently completed. It is a NA study. The enrollment target is 2,502 participants. The study started on 2000-12. Estimated completion is 2016-12.

What interventions are being tested in trial NCT00004732?

The interventions under investigation include: Carotid Endarterectomy (CEA) (PROCEDURE), Carotid Artery Stenting (CAS) (DEVICE).

Who is sponsoring clinical trial NCT00004732?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.